A Pipeline Built on Function
Four programmes across oncology and inflammation and immunology. Each advanced on functional immune-cell data.
| Programme | Format | Development Stage |
|---|---|---|
| programme 01 CB-101 Multiple Myeloma | OR-gated trispecific TCE | Discovery Lead Opt IND-enabling Phase I Phase II |
| programme 02 CB-102 Solid Tumours | Multispecific | Discovery Lead Opt IND-enabling Phase I Phase II |
| programme 03 CB-103 Oncology | Multispecific | Discovery Lead Opt IND-enabling Phase I Phase II |
| programme 04 CB-201 Autoimmune | Multispecific, precision B-cell depletion | Discovery Lead Opt IND-enabling Phase I Phase II |
Programme stage and molecular format are disclosed. Specific antigen targets are not disclosed on this public page.